Section

Moderna Is Pivoting From Covid---the Results Are on Their Way

By wsj - 3 months ago
An approved RSV vaccine on the market this year looks likely, but investors worry about efficacy.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.